Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort Study

Liver Cancer · Published 2026-01-16 · DOI 10.1159/000550356

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000550356

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Early warning for acute pyelonephritis with sepsis: risk prediction model for patients without renal medullary necrosis lesions · Frontiers in Medicine · 2026 · Cites or is cited by this article
• THE REGENERATION PARADOX IN LIVER CANCER:HOW CHRONIC INJURY TRANSFORMS HEALING INTO CARCINOGENESIS · Liver Cancer · 2026 · Same journal
• Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free Strategy · Liver Cancer · 2025 · Same journal
• Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in Japan · Liver Cancer · 2026 · Same journal
• Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular Carcinoma · Liver Cancer · 2026 · Same journal
• Alcohol plays a detrimental role in the prognosis of hepatocellular carcinoma related to steatotic liver disease · Liver Cancer · 2026 · Same journal
• Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched Analysis · Liver Cancer · 2026 · Same journal
• Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab · Liver Cancer · 2025 · Same journal
• Aristolochic Acid and Alternative Lengthening of Telomeres Mechanisms Underlie Liver Angiosarcoma Pathogenesis · Liver Cancer · 2025 · Same journal
• A Phase 1b Study of Lenvatinib plus Nivolumab in Patients with Unresectable Hepatocellular Carcinoma · Liver Cancer · 2026 · Same journal